Organoid Cultures Derived from Patients with Advanced Prostate Cancer
ABC
DEF
GHI
JKL
MNO
PQR
ST
Figure3.HistologyofInSituProstateCancer,3DOrganoids,andXengrafts
(A)H&EofprostatectomyspecimenofpatientMSK-PCa1.(B)H&EoforganoidsofMSK-PCa1.
(C)H&EofsubcutaneousxenograftofMSK-PCa1.
(D)H&EofrightacetabulumwithmetastaticprostatecancerfrompatientMSK-PCa2.
(E)H&EoforganoidsofMSK-PCa2.
(F)H&EofrenalcapsulexenograftofMSK-PCa2.
6Cell159,1–12,September25,2014ª2014Elsevier

Inc.
regenerateprostateglands(Karthausetal.,2014,thisissue).Similarly,thesevenorganoidlines,andtumorgraftsderivedfromtheseorganoidlines,alsodisplayhistologicalpatternspre-sentintheoriginalpatientsample.Forexample,theprimarycan-cerfromwhichMSK-PCa1wasderived,showedanintraductalgrowthpattern(Figure3A),whereasthebonebiopsyspecimenshowedonlysparsetumorcellsthatstainedpositiveforpan-cy-tokeratin(PanCK)andnegativeforAR(FigureS3A,datanotshown).Remarkably,theorganoidlinesderivedfromthisbonemarrowmetastasisrecapitulatedtheintraductalpatternoftheprimarycancer(Figure3B).IHCshowedthattheorganoidswerepositiveforpan-cytokeratinandnegativeforAR,asseeninthecorrespondingbiopsyspecimen(FigureS3A).WhengraftedintoSCIDmice,thetumorsrecapitulatedboththehisto-logicalandimmunohistologicalpatternofthepatientsample(Figures3CandS3A).
ThetissuespecimensofMSK-PCa2,MSK-PCa3,MSK-PCa6andMSK-PCa7showedhigh-gradeadenocarcinoma,mucinousadenocarcinoma(Johnsonetal.,2013),adenocarcinomawithextensivesquamousdifferentiation(Parwanietal.,2004)andGleasonpattern4adenocarcinomawithcribiformgrowth,res-pectively(Figures3D,3G,3P,3S).Thehistologicalpatternofeachoftheseoriginaltumorsisalsoretainedintheorganoids(Fig-ures3E,3H,3Q,3T).TumorsgeneratedbyengraftingMSK-PCa2,MSK-PCa3,andMSK-PCa6intoSCIDmicewerereminiscentofthetumortissue(Figures3F,3I,3R).Interestingly,theCTC-derivedlineMSK-PCa5alsogeneratedorganoidsandgraftsresemblingtheprimarycancer(Figures3M,3N,3O,andS3E).MSK-PCa4isaprostatecancerwithtreatment-inducedneuroendocrinedifferentiationisolatedfromapleuraleffusion.Itdisplaystypicalsmallcellfeaturesincludinghighnucleartocy-toplasicratio,multiplemitotic guresindicativeofrapidprolifer-ation,negativeARandpositivesynaptophysinstainingbothin3Dcultureandwhengraftedinvivo(Figures3J,3K,3L,andS3D).Insummary,patient-derivedorganoidsretainthemicroscopicfeaturesoftheoriginalpatientsampleacrossarangeofhistol-ogies.However,asinglehistologytendstoemergefromsam-pleswithintratumoralheterogeneity(i.e.,MSK-PCa4withbothpan-cytokeratinpositiveandnegativeclonesandMSK-PCa6withbothadenocarcinomaandsquamouscellsdifferentiation).
(G)H&EofretroperitonealmetastasisfrompatientMSK-PCa3.(H)H&EoforganoidsofMSK-PCa3.
(I)H&EofsubcutaneousxenograftofMSK-PCa3.
(J)CytologyofpleuraleffusionfrompatientMSK-PCa4.Arrowspointtoclustersofmalignantcells.
(K)H&EoforganoidsofMSK-PCa4.
(L)H&EofsubcutaneousxenograftofMSK-PCa4.Arrowspointtomitotic gures.
(M)H&EofprostatectomyspecimenofpatientMSK-PCa5.
(N)H&Eofcirculatingtumorcell-derivedorganoidsofMSK-PCa5.(O)H&EofsubcutaneousxenograftofMSK-PCa5.
(P)H&EofextraprostaticprostatecancerfromcystoprostatectomyspecimenofpatientMSK-PCa6.The eldshowncontainsbothadenocarcinomaandsquamousdifferentiationhighlightedinthedottedarea.(Q)H&EoforganoidsofMSK-PCa6.
(R)H&EofsubcutaneousxenograftofMSK-PCa6.(S)H&EoforganoidsofMSK-PCa7.
(T)H&EoforganoidsderivedofMSK-PCa7.
Scalebarsrepresent50mM.SeealsoFigureS3foraccompanyingIHC.
from patients with advanced prostate, bladder, or breast cancer as well as...Regardless of whether the peptidome is derived from the tissue/microenvironment...
[6], advanced melanoma [11], prostate cancer [...from healthy donors and from patients with chronic...In DC cultures of four healthy donors, Freezing ...
热门文档